Please provide your email address to receive an email when new articles are posted on . A guideline for managing patients with acute coronary syndrome was issued by several U.S. societies. The ...

The European Society of Cardiology (ESC) Guidelines on acute coronary syndromes are published online today in European Heart Journal. The document covers the management of unstable angina and all ...

Acute coronary syndrome (ACS) encompasses a spectrum of clinical conditions precipitated by sudden, reduced blood flow to the myocardium. Often resulting from coronary plaque rupture and subsequent ...

“Both the high safety standard and the risk [that] missed ACS poses to patients and clinicians contribute to over-testing, which exposes patients to costs and iatrogenic harm while contributing to ED ...

The American College of Cardiology and the American Heart Association today released an updated clinical practice guideline for managing individuals experiencing acute coronary syndrome (ACS). The ...

PARIS — Adding the PCSK9 inhibitor evolocumab (Repatha, Amgen) to high-intensity statin therapy in the very high-risk setting of acute coronary syndrome (ACS) safely lowers low-density lipoprotein ...

Guidelines continue to recommend standard dual antiplatelet therapy while endorsing de-escalating therapy and monotherapy for some patients. Non-statin lipid-lowering therapies make their debut for ...

Objectives Physical activity (PA) provides protective effects against cardiovascular diseases, including ischaemic heart disease. However, recommending moderate to vigorous PA (MVPA) to patients with ...

Emerging evidence may help reshape antiplatelet and lipid strategies for the management of coronary artery disease.

Dual antiplatelet therapy (DAPT) was not more effective than aspirin alone for the prevention of major adverse cardiovascular events and increased major bleeding in patients with acute coronary ...